The Path to Diagnosis: Genetics and Testing
At a Glance
A positive NIPT or ultrasound finding can suggest Trisomy 18 but does not confirm it. CVS or amniocentesis provides prenatal diagnosis, while postnatal karyotyping confirms the condition and identifies full, mosaic, or partial forms.
Understanding the technical side of a Trisomy 18 diagnosis is a vital step in advocating for your child. The path to a diagnosis often begins with a screening test that raises a “red flag,” followed by more definitive testing to confirm what is happening at the chromosomal level.
The Three Subtypes of Trisomy 18
The impact of Trisomy 18 depends significantly on how many cells are affected and which parts of the chromosome are duplicated. While every child is unique, research highlights distinct differences between the three forms:
- Full (Free) Trisomy 18: The most common form, where an extra chromosome 18 is present in nearly all cells tested [1][2][3]. This typically results in the most severe multisystem challenges, including heart defects (found in about 80% of cases) and significant developmental delays [1][2][3][4][5]. Because this usually results from a random chromosomal separation event, it is almost never inherited.
- Mosaic Trisomy 18: The extra chromosome is only in some cells [6][1][7]. The clinical “picture” varies widely—some children may have signs very similar to full Trisomy 18, while others may have much milder symptoms [6][1][7][6]. Importantly, the percentage of affected cells found in a blood test does not always predict how a child will grow or develop, as different organs may have different levels of mosaicism [8][9][10][8].
- Partial Trisomy 18: Only a specific segment of chromosome 18 is tripled, often from an unbalanced chromosomal rearrangement [11][1][12]. Because the entire chromosome isn’t involved, the outlook and survival can differ significantly from the full form, often depending on exactly which part of the chromosome is extra [11][1][12][11]. In these cases, a genetics referral is vital for discussing recurrence counseling.
Screening vs. Diagnosis: Understanding NIPT
Many families first hear about Trisomy 18 through Non-Invasive Prenatal Testing (NIPT), also called cell-free DNA (cfDNA) screening. It is crucial to understand that NIPT is a screening test, not a diagnostic one [13][14][15][14].
NIPT looks at fragments of DNA in the mother’s blood that come primarily from the placenta [13][14][15]. While NIPT has a high sensitivity for Trisomy 18 (up to 97.7% in some studies), it can produce “false positives” [13][16][13]. In real-world studies, the Positive Predictive Value (PPV)—the chance that a “high risk” result actually means the baby has the condition—was approximately 56% to 80% [13][16][17][18][18]. These PPV numbers are context-dependent ranges that change substantially with pretest probability, maternal age, baseline prevalence, and the specific laboratory method used. Because of this, medical guidelines state that a positive NIPT should always be confirmed with diagnostic testing before making irreversible care decisions whenever a family wants confirmation [19][20][20].
Confirmatory Diagnostic Testing
To get a definitive answer, doctors use tests that look directly at the baby’s cells or the placenta’s core:
- Chorionic Villus Sampling (CVS): Performed between 10 and 13 weeks of pregnancy, this test samples the placenta [21][22][23]. Because it samples placental tissue, it can occasionally be “discordant” (different) from the baby’s actual DNA due to a rare event called confined placental mosaicism [24][24].
- Amniocentesis: Usually performed after 15 weeks, this test samples the fluid around the baby, which contains the baby’s own skin and bladder cells [21][22][23][21]. It is generally considered the most accurate prenatal diagnostic tool [25][26][21][25].
- Postnatal Karyotype: After birth, a blood sample is taken from the baby to confirm the diagnosis [25][27][28][27].
The Role of Ultrasound
Ultrasound findings can raise a strong suspicion of Trisomy 18, but they cannot provide a genetic diagnosis on their own [29][29]. Common markers seen on ultrasound include:
- Fetal growth restriction: The baby is smaller than expected for their age [29][30][31].
- Clenched hands: A characteristic “overlapping finger” position [29][30][31][30].
- Choroid plexus cysts: Small fluid-filled spaces in the brain (though these can also occur in healthy babies) [29][30][31].
- Heart defects: Visible structural issues in the heart [29][30][31][31].
- Micrognathia: A small or recessed chin [29][30][31].
Completeness Checklist: Your Cytogenetic or Genetic Report
When you receive a cytogenetic or genetic report, it should be detailed enough to provide a clear picture. You can use this checklist to review the report with your genetics team:
- [ ] Specimen Source: Does the report clearly state if the cells came from blood, the placenta (CVS), amniotic fluid, or another tissue like a cheek (buccal) swab? [6][10][9][10]
- [ ] Subtype Identified: Does it explicitly name Full, Mosaic, or Partial Trisomy 18? [6][6]
- [ ] Cell Count (Metaphases): For a standard karyotype, the report should state how many cells were analyzed (often 20 or more). If mosaicism is suspected, analyzing a higher number of cells is often required to be accurate, though a blood result alone may miss tissue-specific mosaicism [9][10][28][9].
- [ ] ISCN Notation: Does the report include the official “shorthand” code (e.g.,
47,XY,+18) that specialists use to understand the exact chromosomal arrangement? [6] - [ ] Advanced Testing (If Needed): If the karyotype is unclear, does the report mention FISH (a faster, targeted test for chromosome 18) or Chromosomal Microarray (a high-resolution scan that can find tiny extra pieces of DNA)? [25][27][28][31][28]
Common questions in this guide
Can a positive NIPT result confirm Trisomy 18?
How accurate is NIPT for Trisomy 18?
How do CVS and amniocentesis diagnose Trisomy 18?
What do full, mosaic, and partial Trisomy 18 mean?
What should I look for in a Trisomy 18 genetic report?
Can a normal blood karyotype miss mosaic Trisomy 18?
Can an ultrasound diagnose Trisomy 18?
One line in your results can change your plan.
A positive NIPT result should always be confirmed with diagnostic testing before irreversible care decisions, whenever the family wants confirmation. We check your results against the latest research to help you prepare for what’s next.
Related questions
Get notified when new evidence is published on Trisomy 18 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (31)
- 1
[Mosaic trisomy 18. Series of cases].
Cammarata-Scalisi F, Lacruz-Rengel MA, Araque D, et al.
Archivos argentinos de pediatria 2017; (115(3)):e183-e186 doi:10.5546/aap.2017.e183.
PMID: 28504507 - 2
Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.
Springett A, Wellesley D, Greenlees R, et al.
American journal of medical genetics. Part A 2015; (167A(12)):3062-9 doi:10.1002/ajmg.a.37355.
PMID: 26347425 - 3
Unusual Longevity of Edwards Syndrome: A Case Report.
Alshami A, Douedi S, Guida M, et al.
Genes 2020; (11(12)) doi:10.3390/genes11121466.
PMID: 33297534 - 4
An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18.
Bruns DA, Martinez A
American journal of medical genetics. Part A 2016; (170A(2)):337-343 doi:10.1002/ajmg.a.37427.
PMID: 26453443 - 5
Wilms Tumor in Child With Trisomy 18 and Horseshoe Kidney.
Chen E, Hackney L, VanHeyst K, Miyasaka EA
Journal of pediatric hematology/oncology 2023; (45(8)):e1018-e1022 doi:10.1097/MPH.0000000000002756.
PMID: 37749779 - 6
Phenotypic Spectrum of Trisomy 18 Mosaicism: a New Patient and Literature Review.
Sun W, Wang L, Liu T, et al.
Clinical laboratory 2023; (69(3)) doi:10.7754/Clin.Lab.2022.220610.
PMID: 36912299 - 7
Therapeutic Management and Outcomes of Hepatoblastoma in a Pediatric Patient with Mosaic Edwards Syndrome.
Sosnowska-Sienkiewicz P, Kamińska A, Anderko I, et al.
Genes 2024; (15(4)) doi:10.3390/genes15040463.
PMID: 38674397 - 8
Phenotypic extremes in liveborn monozygotic twins with mosaic Edwards syndrome.
Bussmann N, Cunningham K, Green A, Ryan CA
BMJ case reports 2015; (2015()).
PMID: 26561224 - 9
Prenatal diagnosis of mosaic trisomy 18 and maternal uniparental disomy 18 by amniocentesis in a pregnancy associated with cytogenetic discrepancy in various tissues and a favorable fetal outcome.
Chen CP, Wu FT, Pan YT, et al.
Taiwanese journal of obstetrics & gynecology 2023; (62(4)):606-610 doi:10.1016/j.tjog.2023.05.012.
PMID: 37407205 - 10
Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 18 at amniocentesis in a pregnancy with a favorable fetal outcome and maternal uniparental disomy 18.
Chen CP, Su JW, Chern SR, et al.
Taiwanese journal of obstetrics & gynecology 2022; (61(4)):684-689 doi:10.1016/j.tjog.2022.05.005.
PMID: 35779922 - 11
Strawberry skull in Edwards syndrome.
Mudaliyar US, Mudaliyar SU
BJR case reports 2017; (3(4)):20170045 doi:10.1259/bjrcr.20170045.
PMID: 30363185 - 12
Liveborn children with trisomy 18: A retrospective review.
Armour E, MacPherson MJ, Mack C, et al.
Paediatrics & child health 2025; (30(3)):164-170 doi:10.1093/pch/pxae097.
PMID: 40599664 - 13
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.
Mackie FL, Hemming K, Allen S, et al.
BJOG : an international journal of obstetrics and gynaecology 2017; (124(1)):32-46 doi:10.1111/1471-0528.14050.
PMID: 27245374 - 14
Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
Zhang H, Gao Y, Jiang F, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2015; (45(5)):530-8 doi:10.1002/uog.14792.
PMID: 25598039 - 15
New screen on the block: non-invasive prenatal testing for fetal chromosomal abnormalities.
Filoche S, Lawton B, Beard A, et al.
Journal of primary health care 2017; (9(4)):248-253 doi:10.1071/HC16055.
PMID: 29530134 - 16
Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018-2021).
Lu YS, Chen YY, Ding SY, et al.
Heliyon 2024; (10(13)):e33437 doi:10.1016/j.heliyon.2024.e33437.
PMID: 39040373 - 17
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y, Liu H, He Y, et al.
Human genomics 2020; (14(1)):21 doi:10.1186/s40246-020-00268-2.
PMID: 32503639 - 18
Non-invasive prenatal testing for the diagnosis of congenital abnormalities: Insights from a large multicenter study in southern China.
Cai M, Lin N, Chen X, et al.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2023; (56()):e12506 doi:10.1590/1414-431X2023e12506.
PMID: 37377305 - 19
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S, van Maarle M, Henneman L, et al.
Advances in clinical chemistry 2016; (74()):63-102.
PMID: 27117661 - 20
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
Obstetrics and gynecology 2015; (126(3)):e31-e37 doi:10.1097/AOG.0000000000001051.
PMID: 26287791 - 21
Detection of paternal origin of fetal trisomy 18 in a pregnancy conceived by assisted reproductive technology and in vitro fertilization.
Chen CP, Chern SR, Wang LK, et al.
Taiwanese journal of obstetrics & gynecology 2020; (59(4)):607-609 doi:10.1016/j.tjog.2020.05.024.
PMID: 32653139 - 22
Quantitative fluorescent polymerase chain reaction for rapid prenatal diagnosis of fetal aneuploidies in chorionic villus sampling in a single institution.
Shin YJ, Chung JH, Kim DJ, et al.
Obstetrics & gynecology science 2016; (59(6)):444-453 doi:10.5468/ogs.2016.59.6.444.
PMID: 27896246 - 23
Comparison of quantitative fluorescent polymerase chain reaction and karyotype analysis for prenatal screening of chromosomal aneuploidies in 270 amniotic fluid samples.
Masoudzadeh N, Teimourian S
Journal of perinatal medicine 2019; (47(6)):631-636.
PMID: 31194688 - 24
Chorionic Villus Sampling for Rapid Confirmation of High-Risk NIPT Results for Trisomy 21, 18, and 13.
Srebniak MI, Weerts M, Joosten M, et al.
Prenatal diagnosis 2025; (45(8)):988-993 doi:10.1002/pd.6837.
PMID: 40528522 - 25
Detection of an Underlying 22q11.2 Duplication in a Female Neonate With Trisomy 18.
Turbiville DE, Wu H, Dong J
Laboratory medicine 2017; (48(4)):372-375 doi:10.1093/labmed/lmx039.
PMID: 29036626 - 26
Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Ontario health technology assessment series 2019; (19(4)):1-166.
PMID: 30847010 - 27
Investigation of the diagnostic value of chromosome analysis and bacterial artificial chromosome-based array comparative genomic hybridization in prenatal diagnosis.
Savli H, Keskin SE, Cine N
Turkish journal of medical sciences 2015; (45(6)):1263-7.
PMID: 26775380 - 28
Complex mosaic form of trisomy chromosome 18 and monosomy chromosome X in a girl with esophageal atresia and mild developmental delay: Diagnostic and therapeutic challenge and a review of literature.
Chrzanowska J, Oparska A, Wróblewska A, et al.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2026; (35(7)):1307-1312 doi:10.17219/acem/221563.
PMID: 42267868 - 29
Sensitivity of prenatal ultrasound for detection of trisomy 18.
Becker DA, Tang Y, Jacobs AP, et al.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2019; (32(22)):3716-3722 doi:10.1080/14767058.2018.1471460.
PMID: 29712489 - 30
Prenatal echocardiography in Trisomy 18 - the key to diagnosis and further management in the second half of pregnancy.
Nowakowska A, Sylwestrzak O, Strzelecka I, et al.
Ginekologia polska 2023; (94(5)):366-373 doi:10.5603/GP.a2023.0035.
PMID: 37070966 - 31
Prenatal phenotypic spectrum of full trisomy 18 in an Indian cohort.
Sandal S, Mahay SB, Dimri Gupta N, et al.
American journal of medical genetics. Part A 2022; (188(6)):1904-1908 doi:10.1002/ajmg.a.62692.
PMID: 35191187
This page explains Trisomy 18 screening and diagnostic testing for informational purposes only and does not constitute medical advice or diagnose a pregnancy or child. Review results and next steps with your clinician and a genetic counselor.